Reserch Development
Quality policy
Drug Safety
Cutaden® Bebe
1. Reference documents
2. Corporate Governance Regulation

Export Brochure 

Quality, safety, health and environmental  policy

Annual Report 2014



December 11th - Romanian continuity and performance!
Nowadays, Antibiotice is one of the key drug manufacturers in Romania. Every year new drugs from various therapeutic classes were added to its portfolio so that a balanced product classification was created containing both traditional drugs as well as new generation drugs. 

Net profit goes up 15% in the first 3 months /2015
Today, May 15th, 2015, Antibiotice sent to the Bucharest Stock Exchange the financial results report on the first quarter of 2015.
According to the financial results communicated to the BSE, the net profit recorded a positive trend, reaching 6.06 million LEI, up 15% compared to the same period of 2014. Sales revenue report 3% growth over the Revenues and Expenses budget 2015.

Antibiotice 60 years
From an API manufacturer to pharmaceutical domestic market leader

Copyright 2009 Antibiotice SA Toate drepturile rezervate